Osteopathy of Post Cesarean Section Adhesions
Launched by ADLY A ADAM · Mar 26, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called osteopathic manipulation on women who experience chronic low back pain after having a cesarean section. Adhesions, which are bands of scar tissue that can form after surgery, may contribute to this pain. The goal of the study is to see if this hands-on therapy can help relieve discomfort and improve overall function without using any medications.
To participate in this trial, women need to be aged between 20 and 35 years, have had a cesarean section at least six months prior, and have a body mass index (BMI) of 25 or lower. Participants should not be taking any other pain medications during the study. It's important to note that women who are pregnant, have had recent abdominal surgery, or have certain serious health conditions will not be eligible. If you join the trial, you can expect to receive osteopathic treatment and be monitored for its effects on your back pain. This study is currently not recruiting participants yet, but it aims to provide insight into a drug-free option for managing post-surgery pain.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • They suffered from low back pain and undergoes cesarean section at least 6 months before entry into study.
- • Their body mass index (BMI) will be ≤ 25 kg /m2.
- • Their age will range from 20 to 35 years.
- • They would not use any other analgesic drugs during the study period.
- Exclusion Criteria:
- • Pregnancy or suspected pregnancy.
- • Recent abdominal surgery
- • Patients with severe spinal pathology (cauda equine syndrome, spinal canal stenosis, fracture of spine, discitis, infectious disease of spine).
- • Cancer.
- • Abdominal and pelvic infection, open wound, burn and skin irritation.
About Adly A Adam
Adly A. Adam is a distinguished clinical trial sponsor specializing in the development and oversight of innovative therapeutic solutions. With a commitment to advancing medical research, the organization focuses on conducting rigorous clinical trials that adhere to the highest ethical standards and regulatory guidelines. Leveraging a robust network of healthcare professionals and research institutions, Adly A. Adam aims to facilitate the discovery of new treatments and improve patient outcomes across various therapeutic areas. Their dedication to scientific excellence and collaboration ensures that they remain at the forefront of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Al Miţmar, Qalubyia, Egypt
Patients applied
Trial Officials
Khadija S Abdulaziz, PHD
Study Chair
Professor of Physical Therapy for Woman's Health
Mohamed A Abo Elainin, PHD
Study Director
Consultant of Obstetrics and Gynecology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported